GridAI Technologies (GRDX) Short term Debt (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Short term Debt came in at $6.2 million in Q4 2025, up 792.86% on a QoQ basis from $700000.0 in Q3 2025.

GridAI Technologies (GRDX) Short term Debt (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 5 years of Short term Debt data on file, last reported at $6.2 million in Q4 2025.

Quarterly Short term Debt changed N/A year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (changed N/A YoY) and the FY2025 annual result came in at $6.2 million, changed N/A from the prior year.
Short term Debt improved to $6.2 million in Q4 2025, from $700000.0 in the prior quarter.
In the past five years, Short term Debt ranged from a high of $6.2 million in Q4 2025 to a low of $700000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	GridAI Technologies	6.06 Mn	6.06 Mn	-

Download Data